High density lipoprotein epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Many epidemiological studies link low HDL to the increased risk of [[CHD]] development. | |||
Data from the landmark [[Framingham Heart Study]] showed that for a given level of LDL, the risk of heart disease increases 10-fold as the HDL varies from high to low. | Data from the landmark [[Framingham Heart Study]] showed that for a given level of LDL, the risk of heart disease increases 10-fold as the HDL varies from high to low. | ||
Revision as of 20:34, 20 September 2013
|
High Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Clinical Trials |
|
Case Studies |
|
High density lipoprotein epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of High density lipoprotein epidemiology and demographics |
|
FDA on High density lipoprotein epidemiology and demographics |
|
CDC on High density lipoprotein epidemiology and demographics |
|
High density lipoprotein epidemiology and demographics in the news |
|
Blogs on High density lipoprotein epidemiology and demographics |
|
Risk calculators and risk factors for High density lipoprotein epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Many epidemiological studies link low HDL to the increased risk of CHD development.
Data from the landmark Framingham Heart Study showed that for a given level of LDL, the risk of heart disease increases 10-fold as the HDL varies from high to low.
Epidemiology and Demographics
Epidemiological data showed the significant association of low HDL level as an independent factor, with the development of CHD. For each 1% decrease in HDL level, there is an increase in the risk of CHD development by 2-3%.[1]
A large survey has been set out to determine the prevalence of low HDL in 11 European countries. The study population include 8545 patients receiving treatment for dyslipidaemia, This treatment appeared to exert little or no effect on the prevalence of low HDL-cholesterol, which was slightly higher than that measured in the overall population. Low HDL-cholesterol was present in 33% of men and 40% of women, with very low HDL-cholesterol present in 14% (both genders combined). The prevalence was found much higher in diabetic patients compared to general population. [2]
References
- ↑ National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002). "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report". Circulation. 106 (25): 3143–421. PMID 12485966.
- ↑ "Epidemiology of low HDL-cholesterol: results of studies and surveys". Retrieved 20 September 2013.